Healthcare stocks have jumped, but the easy money has already been made. The ETF, home to health insurers, drugmakers, and ...

There is a huge temptation for income-focused investors to buy the highest-yielding stocks in an effort to boost the cash ...

Apple (NASDAQ: AAPL) started 2025 on a downbeat note as shares of the technology giant headed south for most of January, but the fiscal 2025 first-quarter results it released on Jan. 30 could help ...

In a report released today, Tim Long from Barclays maintained a Sell rating on Apple (AAPL – Research Report), with a price target of $197.00.

The current market environment suggests that traders should adopt a strategy of "buy the dip and sell the rips." The ...

Apple (NASDAQ: AAPL) reported fiscal 2025 first-quarter earnings last week that topped analyst estimates but also contained ...

Apple’s iPhone 16 and Apple Intelligence have disappointed, failing to trigger the expected AI-driven upgrade supercycle. See ...

Apple (NASDAQ:AAPL) wrapped up its December quarter with a strong earnings report last Thursday, delivering both top- and ...

Apple had sold off considerably in the first few weeks of 2025. Meta just hit an all-time high and is still a great buy. Jan.

Apple shares dropped more than 3% on Monday after President Donald Trump announced 10% tariffs on imports from China, where ...

Is CyberArk overvalued despite recent growth from Venafi acquisition? Find out why it's rated as a Hold in this financial ...